CeriBell, Inc. (CBLL)
NASDAQ: CBLL · Real-Time Price · USD
29.16
+1.14 (4.05%)
Dec 3, 2024, 12:24 PM EST - Market open
Company Description
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions.
The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting.
It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015.
The company was incorporated in 2014 and is based in Sunnyvale, California.
CeriBell, Inc.
| Country | United States |
| Founded | 2014 |
| IPO Date | Oct 11, 2024 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 229 |
| CEO | Xingjuan Chao |
Contact Details
Address: 360 North Pastoria Avenue Sunnyvale, California 94085 United States | |
| Phone | 800 436 0826 |
| Website | ceribell.com |
Stock Details
| Ticker Symbol | CBLL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $17.00 |
| CIK Code | 0001861107 |
| ISIN Number | US15678C1027 |
| Employer ID | 47-1785452 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Xingjuan (Jane) Chao, Ph.D. | President, Chief Executive Officer, Co-Founder, and Director |
| Scott Blumberg | Chief Financial Officer |
| Joshua Copp | Chief Business Officer |
| Raymond Woo, Ph.D. | Chief Technology Officer |
| Rebecca (Beckie) Robertson | Chair |
| Juliet Tammenoms Bakker | Director |
| William W. Burke | Director |
| Lucian Iancovici, M.D. | Director |
| Josef Parvizi, M.D., Ph.D. | Director, Co-Founder and Chief Medical Advisor |
| Joseph M. Taylor | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 7, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Oct 22, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Oct 15, 2024 | 8-K | Current Report |
| Oct 11, 2024 | 424B4 | Prospectus |
| Oct 11, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Oct 10, 2024 | EFFECT | Notice of Effectiveness |
| Oct 10, 2024 | CERT | Certification by an exchange approving securities for listing |
| Oct 9, 2024 | FWP | Free Writing Prospectus |